Literature DB >> 19141763

Thyroid-stimulating hormone-receptor antibody and thyroid hormone concentrations in smokers vs nonsmokers with Graves disease treated with carbimazole.

Moffat J Nyirenda, Peter N Taylor, Mary Stoddart, Geoffrey J Beckett, Anthony D Toft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19141763     DOI： 10.1001/jama.2008.931

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Genotype and phenotype predictors of relapse of graves' disease after antithyroid drug withdrawal.

Authors:  Pei-Wen Wang; I-Ya Chen; Suh-Hang Hank Juo; Edward Hsi; Rue-Tsuan Liu; Ching-Jung Hsieh
Journal:  Eur Thyroid J       Date:  2012-10-12

Review 2.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

3.  Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations.

Authors:  Mikael Lantz; Jan Calissendorff; Frank Träisk; Leif Tallstedt; Tereza Planck; Ove Törring; Bengt Hallengren; Peter Åsman
Journal:  Eur Thyroid J       Date:  2016-02-02

4.  The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves' Disease.

Authors:  Ola Lindgren; Pernilla Asp; Anna Sundlöv; Jan Tennvall; Bushra Shahida; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2019-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.